3 Surprisingly Underrated Stocks to Buy Right Now
"I don't get no respect." That was the line the late comedian Rodney Dangerfield made famous. But it could also apply to some stocks.
Three Motley Fool contributors identified surprisingly underrated stocks they think are great picks to buy right now. Here's why they chose (NYSE: ABBV), CRISPR Therapeutics (NASDAQ: CRSP), and Pfizer (NYSE: PFE).
David Jagielski (AbbVie): AbbVie is a top healthcare stock, with a market cap of more than $260 billion. But investors are treating it as if the business is in big trouble. Concerns about a patent cliff and sharply declining sales from Humira are overblown. The stock of a company as diverse and versatile as AbbVie deserves to be trading at a much higher valuation, in my view.
Source Fool.com
AbbVie Inc. Aktie
173,86 €
-1,13 %
Einzigartige Zustimmung für AbbVie Inc. mit ausschließlich Buy-Einschätzungen.
Ein positives Kurspotenzial für AbbVie Inc. ist gegeben, mit einem Kursziel von 180 € über dem aktuellen Kurs von 173.86 €.
